Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer
American Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.62347/hvlf3619 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Lizhi Zhu. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhu, L. (2024). Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/hvlf3619
Vancouver
Zhu L. Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer. American Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.62347/hvlf3619
BibTeX
@article{Zhu2024,
author = {Zhu, Lizhi},
title = {Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.62347/hvlf3619}
}
EUVIMED